Details
Eiromidin Indications
- peripheral nervous system diseases - mono- and polyneuropathy, myasthenia gravis and the myasthenic syndrome of various etiologies;
- CNS diseases: bulbar paralysis and paresis; recovery period of organic CNS lesions that are accompanied by motor disabilities;
- memory disorders of various origins (Alzheimer's disease and other forms of dementia in the elderly), mental retardation in children;
- complex therapy of multiple sclerosis and other forms of demyelinating diseases of the nervous system;
-intestinal atony.
Dosage & Administration
Oral administration.
When neuritis - 1 tablet 2-3 times a day. The course of treatment - 10-15 days in acute neuritis, 20-30 days - in chronic. If necessary, repeat the treatment 2-3 times at intervals of 2-4 weeks to achieve a therapeutic effect.
When mielopoliradikulonevrit with paresis of all extremities and prolonged pain - 1 tablet 2-3 times a day for 30-40 days. The course of treatment is repeated several times with an interval of 1-2 months to achieve a therapeutic effect.
In myasthenia gravis and myasthenic syndromes used 1-2 tablets 2-3 times a day. In severe forms, the dose may be increased to 200 mg / day (2 tablets per day five times in 2-3 h). Treatment course, alternating with traditional anticholinesterase drugs.
Contradictions
Hypersensitivity to ipidacrine, epilepsy, extrapyramidal disorders with hyperkinesis, angina pectoris, bradycardia, asthma, vestibular disorders, mechanical intestinal obstruction or urinary tract, gastric ulcer and duodenal ulcers during pregnancy and lactation.
